This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| THEUER CHARLES | 399,417 | 0 |
| Florence Anthony A. Jr. See Note 2 | 346,600 | 0 |
| BASKETT FOREST See Note 2 | 346,600 | 0 |
| Sonsini Peter W. See Note 2 | 346,600 | 0 |
| New Enterprise Associates 14, L.P. | 346,600 | 0 |
| BARRIS PETER J See Note 2 | 346,600 | 0 |
| MOTT DAVID M See Note 2 | 346,600 | 0 |
| BARRETT M JAMES See Note 2 | 346,600 | 0 |
| KERINS PATRICK J See Note 2 | 346,600 | 0 |
| SANDELL SCOTT D See Note 2 | 346,600 | 0 |
| Viswanathan Ravi See Note 2 | 346,600 | 0 |
| BARRIS PETER J See Note 1 | 275,803 | 0 |
| BASKETT FOREST See Note 1 | 275,803 | 0 |
| Viswanathan Ravi See Note 1 | 275,803 | 0 |
| KOLLURI KRISHNA KITTU See Note 1 | 275,803 | 0 |
| BARRETT M JAMES See Note 1 | 275,803 | 0 |
| Sonsini Peter W. See Note 1 | 275,803 | 0 |
| MOTT DAVID M See Note 1 | 275,803 | 0 |
| SANDELL SCOTT D See Note 1 | 275,803 | 0 |
| Florence Anthony A. Jr. See Note 1 | 275,803 | 0 |
| KERINS PATRICK J See Note 1 | 275,803 | 0 |
| DRANT RYAN D See Note 2 | 188,847 | 0 |
| Weller Harry R See Note 2 | 188,847 | 0 |
| KOLLURI KRISHNA KITTU See Note 2 | 188,847 | 0 |
| JAFCO Super V3 Investment Limited Partnership | 149,705 | 0 |
| Puissance Cross-Border Opportunities V LLC By funds | 76,048 | 0 |
| Brown Scott B. | 21,628 | 0 |
| WIGGINS MARK C | 13,700 | 0 |
| PELLETIER SAUNDRA L | 12,045 | 0 |
| LARUE WILLIAM R | 7,763 | 0 |
| BITAR PATRICIA L | 2,963 | 0 |
| LOGAN H CASEY | 2,775 | 0 |
| SHAZER RONALD L | 33 | 0 |
| Twiford J Rainer By CSA Biotechnology Fund I, LLC | 0 | 0 |
| Walker Paul Edward | 0 | 0 |
| Brookline Tracon Investment Fund II, LLC | 0 | 0 |
| Twiford J Rainer By MCT Investments, LLC | 0 | 0 |
| Opaleye Management Inc. By Opaleye, L.P. | 0 | 0 |
| Shahrestani Neil | 0 | 0 |
| Lam Carol C. | 0 | 0 |
| MATTINGLY MARTIN A | 0 | 0 |
| CSA Biotechnology Fund II, LLC By CSA Biotechnology Fund I, LLC | 0 | 0 |
| Twiford J Rainer By Brookline Tracon Investment Fund, LLC | 0 | 0 |
| Ikarian Capital, LLC | 0 | 0 |
| Wang Theodore T | 0 | 0 |
| Brookline Tracon Investment Fund II, LLC By Brookline Tracon Investment Fund, LLC | 0 | 0 |
| Johnson-Pratt Lisa | 0 | 0 |
| CSA Biotechnology Fund II, LLC By Brookline Tracon Investment Fund, LLC | 0 | 0 |
| Twiford J Rainer By Brookline Tracon Investment Fund II, LLC | 0 | 0 |
| Opaleye Management Inc. By Managed Account | 0 | 0 |
| Twiford J Rainer | 0 | 0 |
| CSA Biotechnology Fund II, LLC By CSA Biotechnology Fund II, LLC | 0 | 0 |
| 0 | 0 | |
| Adams Bonne J. | 0 | 0 |
| Twiford J Rainer By CSA Biotechnology Fund II, LLC | 0 | 0 |
| Opaleye Management Inc. By Managed Account. | 0 | 0 |
| WORLAND STEPHEN T | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|---|---|---|
| THEUER CHARLES | 47,000 | 0.75 | 2023 Apr 27 |
| THEUER CHARLES | 3,999 | 0.66 | 2023 Apr 26 |